drugset / Trial / NCT00790049
A Safety Study of ARRY-371797 in Healthy Subjects
RandomizedParallel-groupQuadruple-blindOther
Summary
This is a Phase 1 study, involving both 1-day and 8-day dosing periods, designed to test the safety of investigational study drug ARRY-371797 in healthy subjects. Approximately 48 healthy subjects from the US will be enrolled in this study.
Timeline
- Start
- 2008-10-31
- Primary completion
- 2009-01-21
- Completion
- 2009-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARRY-371797 | Small molecule | — | Oral |
Indications
No indication recorded.